19 peptides, each graded by how strong the evidence really is.
A fragment of growth hormone once developed as an obesity drug.
One of the most discussed peptides for recovery, with mostly animal research behind it.
An amylin analog being studied alone and in combination with semaglutide.
A modified GHRH analog engineered to last longer in the body.
A four-amino-acid peptide studied in aging research, largely by one research group.
A naturally occurring copper peptide, widely used in topical skincare.
A selective ghrelin-receptor agonist that stimulates growth hormone release.
A natural hormone that sits at the top of the reproductive hormone chain.
A peptide encoded in mitochondrial DNA, studied for its role in metabolism.
A peptide that acts on the brain’s melanocortin system, with one FDA approval.
An investigational "triple agonist" currently in late-stage clinical trials.
A peptide developed in Russia and studied for anxiety and stress.
A GLP-1 receptor agonist and one of the most studied peptide medicines in the world.
A peptide used in Russia and studied for cognition and brain recovery.
A short GHRH fragment with a long research history.
A synthetic peptide related to thymosin beta-4, a protein involved in cell movement and repair.
A growth-hormone-releasing hormone analog with a narrow FDA approval.
An immune-signaling peptide approved as a medicine in some countries.
The first approved medicine that activates both the GIP and GLP-1 receptors.
